The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s00432-014-1768-2
Published Online: 2014-07-09
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sim, Sung Hoon
Keam, Bhumsuk
Kim, Dong-Wan
Kim, Tae Min
Lee, Se-Hoon
Chung, Doo Hyun
Heo, Dae Seog
Text and Data Mining valid from 2014-07-09
Version of Record valid from 2014-07-09
Article History
Received: 27 May 2014
Accepted: 28 June 2014
First Online: 9 July 2014